For research use only. Not for therapeutic Use.
Anti-osteoporosis Agent-7 (CAT: I040463) is a promising small-molecule candidate developed for the treatment of osteoporosis. It demonstrates strong inhibitory activity against osteoclast formation, a key process in bone resorption and skeletal degradation. By targeting osteoclast differentiation or function, Compound 133 helps restore the balance between bone formation and resorption, offering potential therapeutic benefits for bone-loss disorders. Its potent activity in preclinical studies suggests utility in preventing or slowing osteoporosis progression, especially in postmenopausal or age-related cases. Anti-osteoporosis Agent-7 is ideal for further development in bone metabolism research and as a lead compound in bone-targeted drug discovery programs.
| CAS Number | 445254-59-1 |
| Synonyms | azepan-1-yl-[5-[(2,5-dichlorophenoxy)methyl]furan-2-yl]methanone |
| Molecular Formula | C18H19Cl2NO3 |
| Purity | ≥95% |
| IUPAC Name | azepan-1-yl-[5-[(2,5-dichlorophenoxy)methyl]furan-2-yl]methanone |
| InChI | InChI=1S/C18H19Cl2NO3/c19-13-5-7-15(20)17(11-13)23-12-14-6-8-16(24-14)18(22)21-9-3-1-2-4-10-21/h5-8,11H,1-4,9-10,12H2 |
| InChIKey | DQDYJTVTXVFLDC-UHFFFAOYSA-N |
| SMILES | C1CCCN(CC1)C(=O)C2=CC=C(O2)COC3=C(C=CC(=C3)Cl)Cl |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
